New drugs for early Alzheimer’s disease may allow people to live without help for up to 39 additional months, a new study ...

Enzyme designers in the David Baker lab at the University of Washington in Seattle, from the left: Sam Pellock, Anna Lauko, ...

It’s one of the most important higher education decisions before the Legislature this year — when Idaho ranks No. 50 in the ...

A federal judge in Baltimore blocked executive orders signed by President Trump that targeted transgender people and their health care, giving temporary relief to LGBTQ individuals and their families ...

HealthDay News — A federal judge has ordered the US Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) to restore access to public health websites that were ...

It’s more than a financial blow; it’s a betrayal of the families who are depending on breakthroughs in cancer treatment, Alzheimer’s research, and other critical health challenges.” ...

It’s more than a financial blow; it’s a betrayal of the families who are depending on breakthroughs in cancer treatment, Alzheimer’s research, and other critical health challenges.” ...

For children with signs of neurological conditions such as autism, epilepsy and global developmental delay, genetic testing can help make the diagnosis, identify possible treatments and determine ...

WashU Medicine-led trial evaluating investigational drug from Eli Lilly and Company aims to stop disease before symptoms arise Researchers at Washington University School of Medicine in St. Louis have ...

The crucial drugs can have unintended consequences. Innovative therapies could shield the microbiome from their effects.

Robert F. Kennedy Jr. cited a disputed study from a close network of fellow vaccine skeptics during his confirmation hearings ...

Doug Whitney was supposed to develop Alzheimer's by 50. Now scientists are trying to understand why his brain remains healthy ...